who had taken alendronate for at least 5 years in a previous clinical trial -- were randomized to continued treatment (either 5 or 10 mg/day) or placebo. All participants also took 500 mg/day of ...

Romosozumab plus alendronate vs alendronate alone was associated with improved lumbar spine BMD in postmenopausal women with T2D.

In a randomized, double-blind, placebo-controlled, partial cross-over trial, 112 men with nonmetastatic prostate cancer who were receiving ADT were given either alendronate (70 mg once weekly ...